Non-nucleoside reverse transcriptase inhibitor + reverse transcriptase inhibitors (nucleoside + nucleotide analogue). Efavirenz activity is mediated predominantly by noncompetitive inhibition of HIV-1 ...

Read this leaflet carefully before you start taking TENOFOVIR DISOPROXIL VIATRIS. Also, read it each time you get your TENOFOVIR DISOPROXIL VIATRIS prescription refilled, in case something has changed ...

Please provide your email address to receive an email when new articles are posted on . At 5 years, overall survival rates were 54.2% in the entecavir group vs. 64% in the tenofovir disoproxil group.

Please provide your email address to receive an email when new articles are posted on . Previous research has indicated that people living with HIV (PLWH) who switched from Viread (tenofovir ...